Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-03

Clinical Trial Update: Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the safety and efficacy of the Aurolab Artificial Drainage Implant for refractory glaucoma. The study status is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aurolab Artificial Drainage Implant

Snippet

Sponsor: Aurolab | Conditions: Glaucoma | Phase 4 | Status: UNKNOWN